about
A varying-coefficient cox model for the effect of CA19-9 kinetics on overall survival in patients with advanced pancreatic cancerThe Impact of SMAD4 Loss on Outcome in Patients with Advanced Pancreatic Cancer Treated with Systemic ChemotherapyRole of RHOT1 on migration and proliferation of pancreatic cancer.MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells.The Enigma of Rapamycin Dosage.MiR-138: A promising therapeutic target for cancer.Curcumin inhibits the proliferation and invasion of human osteosarcoma cell line MG-63 by regulating miR-138.Chloride intracellular channel 1 (CLIC1) is activated and functions as an oncogene in pancreatic cancer.The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance.Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma.The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis.Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy.USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial-mesenchymal transition through stabilizing SMAD4.A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data.Barrett's esophagus with high grade dysplasia is associated with non-esophageal cancerRoles of Smads Family and Alternative Splicing Variants of Smad4 in Different CancersSunitinib-suppressed miR-452-5p facilitates renal cancer cell invasion and metastasis through modulating SMAD4/SMAD7 signals
P2860
Q33728198-EFC130CC-F384-4A65-9F91-165FF07010FDQ33755454-4E124061-7CAC-4604-AE99-1B895731A17EQ35758011-C049310D-279B-4DE1-9CAC-2EAE3DE6A79BQ36508613-ADFCF6A6-4EC2-4541-9314-A3539879B1DDQ36664900-D5B3D3C1-FA87-43FB-9B03-DE22E50ED808Q38734800-0E9A2456-59CB-4109-A9A0-F11F878A7CA8Q38798406-8C85A3D8-50CA-49AE-8576-5A31970C8B86Q38881347-36BFEF5C-D848-4B5A-9885-92EACEEA0ED5Q39076794-8B4E7785-3076-4175-95C3-0C128E1DC8A2Q39108676-D7B6B4D9-DC22-4115-B479-B5AA14C2A982Q40052237-1C9099E1-F84F-4E4E-9DC8-F9B56FA307E7Q47735303-20453675-4222-48B2-A6AF-7B9A7598C12CQ50911264-613A82AA-2587-4CF0-95C6-F4DB5BF676CCQ55002874-815158C5-D51F-43B1-9F3E-E6902C2B6A72Q57807142-0DE030F1-26AF-45F5-AEE0-938501B8F073Q58556295-D04B7A55-E49F-49E6-B0BC-46C3B1B448D4Q59136865-FECEA72D-D2DD-4634-9B17-48F627C9AEC5
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
SMAD4 and its role in pancreatic cancer.
@en
type
label
SMAD4 and its role in pancreatic cancer.
@en
prefLabel
SMAD4 and its role in pancreatic cancer.
@en
P2093
P2860
P1433
P1476
SMAD4 and its role in pancreatic cancer.
@en
P2093
Chen Huang
Kejian Huang
Weidong Wu
Zhengjun Qiu
P2860
P2888
P304
P356
10.1007/S13277-014-2883-Z
P577
2014-12-03T00:00:00Z
P6179
1020144719